Abstract
Barleria grandiflora Dalz. (Acanthaceae) is being used in India to treat different types of disorders including skin infections. Therefore, there are good possibilities to find antifungal compounds in its extracts with novel mechanism of action. The main objectives of the present study were to evaluate the antifungal activity of plant extracts and to study its effects on metabolic pathways of A. fumigatus. The microbroth dilution assay was used to explore antifungal activity and MIC of various extracts. Metabolic profiles of control and treated cultures were collected from Q-TOF-MS interfaced with HPLC. Affected metabolic pathways of A. fumigatus after the treatment were analyzed by discrimination analysis of mass data. Antifungal activities were observed in hot and cold water extracts of the plant. Hot water extract of B. grandiflora showed significant activity against tested fungi in the range 0.625–1.25 mg/mL. Partial least discrimination analysis revealed that the hot water plant extract downregulated amino acid, glyoxylate pathway, and methylcitrate pathways at the same time due to the synergistic effects of secondary metabolites. Hot water extract also downregulated several other metabolic pathways unique to fungi indicating its specific activity toward fungi. B. grandiflora showed promising antifungal activity which can further be exploited by identification of active compounds, to inhibit the specific fungal pathways and development of novel therapeutic antifungal drugs.
Similar content being viewed by others
References
Dagenais, T. R., & Keller, N. P. (2009). Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clinical Microbiology Reviews, 22(3), 447–465.
Denning, D. W. (1998). Invasive aspergillosis. Clinical infectious diseases, 781–803.
Ringden, O., Soderdahl, G., Mattsson, J., Uzunel, M., Remberger, M., Hentschke, P., & Ericzon, B. G. (2000). Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer 1. Transplantation, 69, 2043–2048.
Brock, M., Jouvion, G., Droin-Bergere, S., Dussurget, O., Nicola, M. A., & Ibrahim-Granet, O. (2008). Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis. Applied and Environmental Microbiology, 74(22), 7023–7035.
Groll, A. H., Piscitelli, S. C., & Walsh, T. J. (1998). Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development. Advances in Pharmacology, 44, 343–500.
Kontoyiannis, D. P., & Lewis, R. E. (2002). Antifungal drug resistance of pathogenic fungi. The Lancet, 359, 1135–1144.
Chandrasekar, P. H., & Manavathu, E. (2001). Voriconazole: a second-generation triazole. Drugs Today, 37, 135–148.
Prentice, H. G., Hann, I. M., Herbrecht, R., Aoun, M., Kvaloy, S., Catovsky, D., & Gibson, B. E. S. (1997). A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology, 98(3), 711–718.
Hiemenz, J. W., & Walsh, T. J. (1996). Lipid formulations of amphotericin B: recent progress and future directions. Clinical Infectious Diseases, 22(Supplement 2), S133–S144.
Santos, A. (2011). Aspartic proteases of human pathogenic fungi are prospective targets for the generation of novel and effective antifungal inhibitors. Current Enzyme Inhibition, 7(2), 96–118.
Guo, T., & Hobbs, D. W. (2003). Privileged structure-based combinatorial libraries targeting G protein-coupled receptors. Assay and Drug Development Technologies, 1(4), 579–592.
Ye, Z. H., Garrad, R. C., Winston, M. K., & Bhattacharjee, J. K. (1991). Use of α‐aminoadipate and lysine as sole nitrogen source by Schizosacharomyces pombe and selected pathogenic fungi. Journal of Basic Microbiology, 31(2), 149–156.
Aneja, K. R., Joshi, R., & Sharma, C. (2010). Potency of Barleria prionitis L. bark extracts against oral diseases causing strains of bacteria and fungi of clinical origin. New York Science Journal, 3, 5–12.
Sawarkar, H. A., Khadabadi, S. S., Wandhare, M. D., Farooqui, I. A., & Deokate, U. A. (2009). The antioxidant activity of the leaves of Barleria grandiflora dalz.(acanthaceae). Ethnobotanical Leaflets, 4, 3.
Dabur, R., Chhillar, A. K., Yadav, V., Kamal, P. K., Gupta, J., & Sharma, G. L. (2005). In vitro antifungal activity of 2-(3, 4-dimethyl-2, 5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate, a dihydropyrrole derivative. Journal of Medical Microbiology, 54(6), 549–552.
Vitale, R. G., Mouton, J. W., Afeltra, J., Meis, J. F., & Verweij, P. E. (2002). Method for measuring post-antifungal effect in Aspergillus species. Antimicrobial Agents and Chemotherapy, 46(6), 1960–1965.
Ibrahim‐Granet, O., Dubourdeau, M., Latge, J. P., Ave, P., Huerre, M., Brakhage, A. A., & Brock, M. (2008). Methylcitrate synthase from Aspergillus fumigatus is essential for manifestation of invasive aspergillosis. Cellular Microbiology, 10(1), 134–148.
d'Enfert, C. (1996). Selection of multiple disruption events in Aspergillus fumigatus using the orotidine-5′-decarboxylase gene, pyrG, as a unique transformation marker. Current Genetics, 30(1), 76–82.
Vodisch, M., Scherlach, K., Winkler, R., Hertweck, C., Braun, H. P., Roth, M., & Kniemeyer, O. (2011). Analysis of the Aspergillus fumigatus proteome reveals metabolic changes and the activation of the pseurotin A biosynthesis gene cluster in response to hypoxia. Journal of Proteome Research, 10(5), 2508–2524.
Panaccione, D. G. (2005). Origins and significance of ergot alkaloid diversity in fungi. FEMS Microbiology Letters, 251(1), 9–17.
Magasanik, B. (1992). in The Molecular and Cellular Biology of the Yeast Saccharomyces: Gene Expression (eds. Jones, E.W., Pringle, J.R. & Broach, J.R.) 283–318 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor).
Chen, E. J., & Kaiser, C. A. (2003). LST8 negatively regulates amino acid biosynthesis as a component of the TOR pathway. The Journal of Cell Biology, 161(2), 333–347.
Mark Zabriskie, T., & Jackson, M. (2000). Lysine biosynthesis and metabolism in fungi. Natural Product Reports, 17(1), 85–97.
Odds, F. C. (2005). Genomics, molecular targets and the discovery of antifungal drugs. Revista Iberoamericana de Micologia, 22(4), 229–237.
Schobel, F., Jacobsen, I. D., & Brock, M. (2010). Evaluation of lysine biosynthesis as an antifungal drug target: biochemical characterization of Aspergillus fumigatus homocitrate synthase and virulence studies. Eukaryotic Cell, 9(6), 878–893.
Kubicek, C. P., Punt, P. E., & Visser, J. (2010). Production of organic acids by filamentous fungi. Industrial Applications, 10, 215.
Ruijter, G. J. G., Kubicek, C. P., Visser, J. (2002). in Osiewacz HD (ed), vol 10: Industrial applications (The Mycota,) Springer, Berlin Heidelberg New York, pp. 213–230.
Reeves, E. P., Nagl, M., O'Keeffe, J., Kelly, J., & Kavanagh, K. (2006). Effect of N-chlorotaurine on Aspergillus, with particular reference to destruction of secreted gliotoxin. Journal of Medical Microbiology, 55(7), 913–918.
Stapleton, P. P., Redmond, H. P., & Bouchier-Hayes, D. J. (1998). Myeloperoxidase (MPO) may mediate neutrophil adherence to the endothelium through upregulation of CD11B expression—an effect downregulated by taurine. Advances in Experimental Medicine and Biology, 442, 183–192.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumari, S., Jain, P., Sharma, B. et al. In Vitro Antifungal Activity and Probable Fungicidal Mechanism of Aqueous Extract of Barleria Grandiflora . Appl Biochem Biotechnol 175, 3571–3584 (2015). https://doi.org/10.1007/s12010-015-1527-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-015-1527-0